Programme
The ESMO TAT Virtual Congress 2021 virtual programme is now online!
ESMO Targeted Anticancer Therapies Virtual Congress 2021
- Start date
- 01 Mar 2021
- End date
- 02 Mar 2021
ESMO Targeted Anticancer Therapies Virtual Congress 2021: the Home of Phase I in Oncology
The ESMO Targeted Anticancer Therapies Virtual Congress 2021, known as “The Home of Phase I in Oncology” will offer participants a glimpse of the future of targeted anticancer therapies.
It is the premier international meeting focusing on promising new anticancer targets and agents, with a particular focus on those in early phase clinical development. Stakeholders from academy and industry will discuss with clinicians, researchers and regulators the global dissemination of knowledge and clinical research expertise in the field of innovative cancer therapeutics, to the benefit of cancer patients worldwide.
Organisation
ESMO Head Office
Via Ginevra 4
6900 Lugano
Switzerland
meetings@esmo.org
Abstracts
Abstracts submission for TAT 2021 is now open.
Congress Officers
Find out the TAT 2021 Scientific Commitee Co-Chairs and Members
Sponsors
Find out more information about the sponsors of TAT 2021
Industry Participation
Industry partners: find out how to get involved
Contacts
Get in touch with the organisers of TAT 2021.